1 |
Bonfield TL, Sutton MT, Fletcher DR, Reese-koc J, Roesch EA, Lazarus HM, Chmiel JF, Caplan AI. Human Mesenchymal Stem Cell (hMSC) Donor Potency Selection for the “First in Cystic Fibrosis” Phase I Clinical Trial (CEASE-CF). Pharmaceuticals 2023;16:220. [DOI: 10.3390/ph16020220] [Reference Citation Analysis]
|
2 |
de Kanter AJ, Jongsma KR, Verhaar MC, Bredenoord AL. The Ethical Implications of Tissue Engineering for Regenerative Purposes: A Systematic Review. Tissue Engineering Part B: Reviews 2022. [DOI: 10.1089/ten.teb.2022.0033] [Reference Citation Analysis]
|
3 |
Li JZ, Meng SS, Xu XP, Huang YB, Mao P, Li YM, Yang Y, Qiu HB, Pan C. Mechanically Stretched Mesenchymal Stem Cells Can Reduce the Effects of LPS-Induced Injury on the Pulmonary Microvascular Endothelium Barrier. Stem Cells Int 2020;2020:8861407. [PMID: 33178288 DOI: 10.1155/2020/8861407] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
|
4 |
Wagner DE, Ikonomou L, Gilpin SE, Magin CM, Cruz F, Greaney A, Magnusson M, Chen YW, Davis B, Vanuytsel K, Rolandsson Enes S, Krasnodembskaya A, Lehmann M, Westergren-Thorsson G, Stegmayr J, Alsafadi HN, Hoffman ET, Weiss DJ, Ryan AL. Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Disease 2019. ERJ Open Res 2020;6:00123-2020. [PMID: 33123557 DOI: 10.1183/23120541.00123-2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
5 |
Al-Qahtani W, Abdel Jabar M, Masood A, Jacob M, Nizami I, Dasouki M, Abdel Rahman AM. Dried Blood Spot-Based Metabolomic Profiling in Adults with Cystic Fibrosis. J Proteome Res 2020;19:2346-57. [PMID: 32312052 DOI: 10.1021/acs.jproteome.0c00031] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|